Onyx Pharmaceuticals Inc., the cancer biopharmaceutical company, signed for 126,493 square feet at 249 E. Grand Ave. in South San Francisco, CA. The deal includes 68,738 square feet subleased from Exelixis and the entire first and second floor space leased…
No comments yet.
Sorry, the comment form is closed at this time.